Furthermore, we overexpressed ASPHH675Q in ETK1, NEC, RBE, and SSP25 cell lines with relatively higher levels of endogenous ASPH expression and subsequently evaluated the effects on the CCA malignant phenotype. The gene discussed is ASPH; the disease is cholangiocarcinoma.